ALUMIS INC. 4

Chief Scientific Officer David M. Goldstein sold 2,596 shares of Alumis Inc. common stock on 2026-08-03 in a mandatory sell-to-cover transaction at a weighted-average price of about $26.37 per share.

On August 3, 2026, Alumis Inc. Chief Scientific Officer David M. Goldstein sold 2,596 shares of Alumis Inc. common stock at a weighted-average price of approximately $26.37 per share, for proceeds of about $68,460, in a sale characterized as a mandatory sell-to-cover transaction to satisfy tax obligations arising from previously granted restricted stock units rather than a discretionary sale. Following the transaction, Goldstein continued to hold 30,970 shares directly, and additional indirect holdings of 208,237 shares through the Baily Goldstein Living Trust and 8,994 shares held by family members residing in his household, leaving him with a substantial ongoing equity position in the company.

Filing Facts

CIK

1847367

Ticker

ALMS

Form

4

Source Type

fda

Accession

0001751719-26-000008

Alert Tier

5